Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Leidos | LDOS | 13. nov 2024 | 194.40 | -3.41 |
LeMaitre Vascular | LMAT | 13. nov 2024 | 102.57 | -0.67 |
Lemonade | LMND | 13. nov 2024 | 31.99 | -0.87 |
LendingClub | LC | 13. nov 2024 | 15.55 | -0.83 |
LendingTree | TREE | 13. nov 2024 | 49.82 | -7.76 |
Lendway | LDWY | 13. nov 2024 | 3.66 | +4.87 |
Lennar A | LEN | 13. nov 2024 | 166.33 | +0.09 |
Lennar B | LEN-B | 13. nov 2024 | 157.72 | +0.29 |
Lennox International | LII | 13. nov 2024 | 619.34 | +0.53 |
LENSAR | LNSR | 13. nov 2024 | 7.39 | +4.97 |
LENZ Therapeutics | LENZ | 13. nov 2024 | 36.34 | -2.44 |
Leonardo DRS | DRS | 13. nov 2024 | 36.13 | 0.00 |
Lesaka Technologies | LSAK | 13. nov 2024 | 5.12 | -2.10 |
Leslies | LESL | 13. nov 2024 | 2.87 | -1.37 |
Levi Strauss & Co A | LEVI | 13. nov 2024 | 16.98 | +0.71 |
Lexaria Bioscience | LEXX | 13. nov 2024 | 2.26 | -1.74 |
Lexeo Therapeutics | LXEO | 13. nov 2024 | 7.64 | -0.65 |
Lexicon Pharmaceuticals | LXRX | 13. nov 2024 | 1.09 | -8.40 |
LexinFintech ADR | LX | 13. nov 2024 | 3.12 | -2.50 |
LG Display ADR | LPL | 13. nov 2024 | 3.34 | -2.34 |
LGI Homes | LGIH | 13. nov 2024 | 103.93 | -0.96 |
LGL Group | LGL | 13. nov 2024 | 5.92 | +0.81 |
Li Auto ADR | LI | 13. nov 2024 | 22.35 | -1.15 |
Li Bang International | LBGJ | 13. nov 2024 | 4.15 | 0.00 |
Li-Cycle | LICY | 13. nov 2024 | 2.58 | -2.27 |
Liberty Allstar Equity Fund | USA | 13. nov 2024 | 7.46 | +0.13 |
Liberty Allstar Growth Fund | ASG | 13. nov 2024 | 5.97 | -0.17 |
Liberty Broadband A | LBRDA | 13. nov 2024 | 92.23 | -4.67 |
Liberty Broadband A Pref | LBRDP | 13. nov 2024 | 24.07 | +1.18 |
Liberty Broadband C | LBRDK | 13. nov 2024 | 92.69 | -5.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.